Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Feasibility of a 4-Week Intensive Postoperative Multimodal Rehabilitation Program in Complicated Patients After Proximal Pancreatectomy: A Prospective Single-Cohort Study (REACT)

14 de agosto de 2026 atualizado por: Nicolò Pecorelli, IRCCS San Raffaele

The REACT study is a prospective, single-center, single-cohort study designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).

Postoperative complications after pancreatic surgery may result in substantial physiological and metabolic stress, leading to loss of muscle mass, malnutrition, reduced functional capacity, and delayed recovery. Although prehabilitation programs have been proposed to improve patients' functional capacity before surgery, evidence regarding structured multimodal rehabilitation after pancreatic surgery is currently lacking.

Adult patients undergoing elective proximal pancreatic resection who develop a severe postoperative complication (Comprehensive Complication Index >21) will be eligible for the study. Participants will undergo a 4-week multimodal rehabilitation program starting after hospital discharge and including individualized exercise training, nutritional therapy, and anxiety-reducing techniques. The program may be delivered either in a supervised hospital-based setting or through a home-based program according to patient preference and availability.

The primary objective is to assess the feasibility of the rehabilitation program in terms of recruitment, adherence, completion of outcome assessments, completeness of data, and safety. Secondary objectives include evaluating postoperative functional recovery using PROMIS-29 Physical and Mental Health Summary Scores, the 6-minute walk test, and the Duke Activity Status Index. In patients with malignancy who are candidates for adjuvant treatment, return to intended oncologic treatment will also be evaluated.

A total of 40 patients will be enrolled and followed for up to 90 days after surgery.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Intervenção / Tratamento

Descrição detalhada

Pancreatic surgery is associated with a high rate of postoperative morbidity. Postoperative complications may impose substantial physiological and metabolic stress, leading to depletion of functional reserves, loss of muscle mass and energy stores, malnutrition, sarcopenia, and reduced functional capacity. Recovery may be particularly prolonged in patients experiencing severe postoperative complications and in frail patients with limited physiological and metabolic reserves. Although multimodal prehabilitation has been proposed to improve functional capacity before major surgery, evidence supporting the role of structured multimodal rehabilitation in improving recovery after pancreatic resection is currently lacking.

REACT is a prospective, single-center, single-cohort, low-interventional clinical study conducted at IRCCS Ospedale San Raffaele, Milan, Italy. The study is designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection. All enrolled participants will receive the multimodal rehabilitation intervention in addition to standard postoperative care; no formal comparator group is included.

The study population will include adult patients undergoing elective proximal pancreatic resection, defined as pancreatoduodenectomy or total pancreatectomy, who develop a severe postoperative complication during their hospital stay, defined according to a Comprehensive Complication Index (CCI) >21.

The multimodal rehabilitation program will start during the first week after postoperative hospital discharge and will last 4 weeks. The intervention includes exercise training, nutritional therapy, and anxiety-reducing techniques and will be individualized according to the patient's physical, nutritional, psychological, and clinical condition. Activities will be performed under the supervision of qualified healthcare professionals, including physiotherapists, nutritionists, and psychology-trained personnel.

The exercise component will include endurance, resistance, and breathing exercises tailored to the individual patient's clinical condition. Endurance training will consist of progressively increasing moderate-intensity continuous training, with intensity adjusted according to patient performance and perceived exertion using the Borg scale. Resistance exercises will involve different upper- and lower-limb muscle groups, with progressive workload adjustments based on individual performance. The program will include two to three supervised training sessions per week, with a minimum frequency of three exercise sessions per week specified for the overall program.

Exercise rehabilitation may be delivered either in a hospital-based or home-based setting according to patient preference and availability. Hospital-based exercise sessions will be conducted in the hospital gym. For patients following the home-based program, the hospital-based intervention will be adapted while maintaining the same overall duration, therapeutic goals, and monitoring approach. Outdoor walking may replace treadmill- or cycle-based aerobic exercise when equipment is unavailable, while resistance exercises will be performed using resistance bands provided by the study center. Educational materials, video demonstrations, and monitoring devices will be provided when appropriate.

The nutritional component will consist of an individualized dietary management plan based on dietary habits, medical conditions, and nutritional status. A balanced food-based intervention will be prescribed to meet estimated caloric and nutritional requirements. A daily protein intake of 1.5-2.0 g/kg of ideal body weight will be recommended, and whey protein supplementation may be prescribed when needed. Participants will also receive instruction on anxiety-reducing strategies, including imagery, visualization, and deep-breathing techniques.

The primary objective of the study is to assess the feasibility of the 4-week multimodal rehabilitation program. Feasibility will be evaluated according to five predefined criteria: at least 50% of eligible patients agree to participate; at least 80% of enrolled patients adhere to the program; at least 80% of participants complete an outcome assessment after rehabilitation; the proportion of missing data among patients completing outcome assessments is below 10%; and no serious adverse events related to the rehabilitation program occur. The intervention will be considered feasible only if all five predefined criteria are met.

Adherence will be defined as completion of at least 80% of the planned intervention components, including exercise sessions, nutritional consultations, and psychological support sessions. For hospital-based rehabilitation, adherence will be documented by the rehabilitation team, while adherence to the home-based program will be assessed using patient diaries reviewed during regular telephone contacts. An exploratory subgroup analysis will compare feasibility outcomes between hospital-based and home-based rehabilitation.

Secondary objectives will evaluate functional recovery following surgery. Outcomes will include the Patient-Reported Outcomes Measurement Information System-29 (PROMIS-29) Physical Health Summary Score and Mental Health Summary Score, the 6-minute walk test (6MWT), and the Duke Activity Status Index (DASI). Recovery will be assessed in relation to preoperative values and predefined minimal important differences. Assessments will be performed preoperatively, at hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery. In patients with malignancy who are candidates for adjuvant treatment, time to return to intended oncologic treatment (RIOT) will also be evaluated.

Safety will be assessed by monitoring, recording, and analyzing adverse events occurring during the study, with particular attention to events potentially related to exercise training, nutritional intervention, or psychological support. Routine clinical assessments performed as part of standard postoperative care will also contribute to the safety evaluation.

The planned sample size is 40 participants. Assuming an expected adherence rate of 80%, this sample size allows adherence to be estimated with a 95% confidence interval of approximately ±12 percentage points and is considered appropriate for the pilot feasibility objective of the study. Enrollment is planned over 12 months, the rehabilitation intervention will last 4 weeks, and participants will be followed for up to 3 months.

Tipo de estudo

Intervencional

Inscrição (Estimado)

40

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Descrição

  • Inclusion Criteria:
  • Age ≥18 years.
  • Patients undergoing elective proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).
  • Patients developing a severe postoperative complication during their hospital stay, defined as a Comprehensive Complication Index (CCI) >21.
  • Exclusion Criteria:
  • Metastatic disease.
  • Surgical procedures other than pancreatoduodenectomy or total pancreatectomy.
  • Inability to speak Italian.
  • Cognitive impairment or illiteracy resulting in inability to read and understand the Italian language.
  • Medical conditions contraindicating the rehabilitation regimen (exercise and nutritional intervention), including orthopedic or cognitive disabilities and chronic renal failure (dialysis or creatinine >250 mmol).
  • Pregnancy.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Multimodal Postoperative Rehabilitation
Participants will receive a 4-week intensive multimodal postoperative rehabilitation program starting during the first week after hospital discharge. The program includes individualized exercise training, nutritional therapy, and anxiety-reducing techniques, tailored to each participant's clinical, physical, nutritional, and psychological condition. Exercise training will be delivered either in a supervised hospital-based setting or through a home-based program according to patient preference and availability. All participants will receive the multimodal rehabilitation program in addition to standard care
Participants will undergo a 4-week multimodal postoperative rehabilitation program starting during the first week after hospital discharge. The program includes individualized exercise training, nutritional therapy, and anxiety-reducing techniques. Exercise includes moderate-intensity endurance, resistance, and breathing exercises tailored to the patient's clinical condition and may be delivered in a hospital-based or home-based setting. Nutritional therapy consists of an individualized dietary plan, with a recommended protein intake of 1.5-2.0 g/kg of ideal body weight and whey protein supplementation if needed. Participants will also receive instruction in relaxation techniques, including imagery, visualization, and deep-breathing exercises. The program is delivered by qualified physiotherapists, nutritionists, and psychology-trained personnel.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Feasibility of the multimodal postoperative rehabilitation program
Prazo: At the end of the 4-week rehabilitation program

Feasibility will be assessed according to five predefined criteria:

  1. ≥50% of eligible patients agree to participate;
  2. ≥80% of enrolled patients adhere to the program;
  3. ≥80% complete the post-rehabilitation outcome assessment;
  4. missing data among patients completing outcome assessments are <10%; (5) no serious adverse events related to the rehabilitation program occur.

The intervention will be considered feasible only if all five criteria are met.

At the end of the 4-week rehabilitation program

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
PROMIS-29 Physical Health Summary Score recovery
Prazo: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative PROMIS-29 Physical Health Summary Score (PHS) or show a decline smaller than the minimal important difference (MID) of 2.3 points.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
PROMIS-29 Mental Health Summary Score recovery
Prazo: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative PROMIS-29 Mental Health Summary Score (MHS) or show a decline smaller than the minimal important difference (MID) of 2.3 points.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Six-Minute Walk Test recovery
Prazo: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative 6-minute walk test (6MWT) performance or show a decline smaller than the minimal important difference of 19 meters.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Duke Activity Status Index recovery
Prazo: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative Duke Activity Status Index (DASI) or show a decline smaller than the minimal important difference of 6 METs.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de setembro de 2026

Conclusão Primária (Estimado)

31 de março de 2027

Conclusão do estudo (Estimado)

31 de março de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

11 de agosto de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

14 de agosto de 2026

Primeira postagem (Real)

17 de agosto de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de agosto de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

14 de agosto de 2026

Última verificação

1 de agosto de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • REACT

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .